Navidea Biopharmaceuticals Announces Panel Participation at the Biotech Showcase Conference
– Thomas Tulip, EVP and CBO, panelist in the Molecular Diagnostic Workshop –
DUBLIN, Ohio--(BUSINESS WIRE)-- Navidea Biopharmaceuticals (NYSE Amex: NAVB) today announced that Thomas Tulip, Executive Vice President and Chief Business Officer of Navidea, will participate with five other biopharmaceutical executives as an expert panelist in a workshop entitled, Molecular Diagnostics: A Sector of Increasing Importance on Wednesday, January 11, 2012 from 8:00 AM – 9:00 AM PT at the Biotech Showcase Conference in San Francisco. The workshop will explore the challenges and opportunities within the Molecular diagnostic sector.
About Navidea Biopharmaceuticals
Navidea Biopharmaceuticals (NYSE Amex: NAVB) is a biopharmaceutical company focused on the development and commercialization of precision diagnostics and radiopharmaceutical agents. Navidea is actively developing three radiopharmaceutical agent platforms – Lymphoseek®, AZD4694 and RIGScanTM – to help identify the presence and status of undetected disease and enable better diagnostic accuracy, clinical decision-making and ultimately patient care. Navidea’s strategy is to deliver superior growth and shareholder return by bringing to market novel radiopharmaceutical agents and advancing the Company’s pipeline through selective acquisitions, global partnering and commercialization efforts. For more information, please visit www.navidea.com.
About the Biotech Showcase™ (Innovation – Opportunity – Collaboration):
Now in its fourth year, Biotech Showcase™ will feature corporate presentations by 200+ innovative life science companies to an audience of public and private investors, business development executives and professional advisors who are interested in investment opportunities and collaboration. The showcase takes place during the week of one of the most important healthcare investor conferences which annually attracts thousands of healthcare and life science business executives to San Francisco in a venue located close to the center of action. To maximize efficiency, all showcase participants can schedule one-on-one meetings through the organizer’s online system, partneringONE®. Public and private investors are always invited to attend the showcase on a complimentary basis. Biotech Showcase was co-founded by Demy-Colton Life Science Advisors and EBD Group, two organizations that have a long and successful history building programs that meet the needs of the life sciences industry. Visit our website for more information: www.ebdgroup.com/bts.
Navidea Biopharmaceuticals
Brent Larson, 614-822-2330
Sr.
VP & CFO
Source: Navidea Biopharmaceuticals
Released January 9, 2012